
|Articles|January 6, 2017
Decrease in FDA Drug Approvals Highlight Specialty Pharmacy Week in Review
Author(s)Davy James, Managing Editor
Top articles of the week from Specialty Pharmacy Times.
Advertisement
[<a href="//storify.com/pharmacytimes/decrease-in-fda-drug-approvals-highlight-specialty" target="_blank">View the story "Decrease in FDA Drug Approvals Highlight Specialty Pharmacy Week in Review" on Storify</a>]
Newsletter
Stay informed on drug updates, treatment guidelines, and pharmacy practice trends—subscribe to Pharmacy Times for weekly clinical insights.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Tradipitant Becomes First Treatment Approved for Vomiting Due to Motion Sickness in 4 Decades
2
FDA Approves Denosumab Biosimilars Boncresa and Oziltus for Osteoporosis-, Cancer-Related Bone Loss
3
Aspirin Dosage and Decision-Making: What Pharmacists Should Know
4
'Beyond Weight Loss': Emerging Studies Show How GLP-1 Receptor Agonists May Impact Addiction Behaviors
5












































































































































































































